Mylan Files Regulatory Notifications For Perrigo Takeover Offer
This article was originally published in The Tan Sheet
Mylan files notifications with FTC and DoJ required under U.S. antitrust laws. Mylan Chairman Robert says the filing is an “important step in our ongoing determination to make this compelling proposed combination a reality.”
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.